HOME >> BIOLOGY >> NEWS
New placenta screening for high-risk pregnancies

Toronto, ON (April 2, 2007) -- For the first time ever, a team of Toronto researchers are using a combination of ultrasound and blood tests to screen high-risk pregnant mothers for placental damage. By completing these non-invasive tests, most high-risk mothers can be reassured that their placenta is formed and functioning properly, so they can expect a healthy pregnancy. The tests are done early enough, at 16 to 23 weeks gestation, so if results are abnormal, physicians have time to improve pregnancy outcomes. Close to 40 per cent of high-risk mothers we see in our clinic experience placental damage, says Dr. John Kingdom, Principal Investigator of the study and Maternal-Fetal Medicine Specialist at Mount Sinai Hospital. The research is among the first to look at placenta health a vital life line between mother and fetus through which nutrients, oxygen, antibodies and hormones pass.

By identifying early on if there is a potential risk of complications, we can do everything possible to ensure the safety of both the mother and fetus, says Dr. Kingdom, who is also a Professor in the Department of Obstetrics and Gynaecology at the University of Toronto. We can reassure those with normal test results that their placentas are functioning well and they can expect a healthy pregnancy and birth.

If the placenta is not functioning properly it could be a potential danger to the health of the mother and fetus. Abnormalities can lead to conditions such as preeclampsia, which is maternal high blood pressure, stillbirth or the need for a pre-term delivery.

The screening tests include: a maternal serum screening test used to detect Downs syndrome, which measures the hormone levels in the mothers blood; a uterine artery Doppler blood flow test, which checks the maternal blood flow in the placenta; and an ultrasound of the placental shape. Of the 212 high-risk women in the study, 19 delivered early due to poor fetal growth. None of these women h
'"/>

Contact: Jodi Salem
416-586-3161
University of Toronto
2-Apr-2007


Page: 1 2

Related biology news :

1. 100 percent of pregnant women have at least one kind of pesticide in their placenta
2. Robust time estimation reconciles views of the antiquity of placental mammals
3. Tumor-suppressor gene is critical for placenta development
4. Key to early diagnosis of autism may be in the placenta
5. New research links placenta praevia directly to assisted reproductive techniques
6. Discarded placentas deliver researchers promising cells similar to embryonic stem cells
7. ACMG recognizes progress made in newborn screening
8. Nearly 90 percent of babies receive recommended newborn screening tests
9. Pre-implantation genetic screening reduces both ongoing pregnancy and live birth rates in over 35s
10. Changes in chromosomal constitution of preimplantation embryos suggest caution in genetic screening
11. Noninvasive screening in early pregnancy reduces Downs births by 50 percent

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/17/2019)... ... July 18, 2019 , ... ... Meredith James, HT, PMP, to its executive team as Vice President of Operations. ... drug development. In her new role, Ms. James is responsible for ensuring on-time ...
(Date:7/17/2019)... ... 15, 2019 , ... RCH Solutions (RCH), a ... companies, announces the availability of new specialty advisory practice, a Public Cloud Managed ... emerging bio-pharma companies interested in achieving specific outcomes related to public Cloud adoption. ...
(Date:7/17/2019)... ... ... Imagine using a simple, portable test to detect cancer before malignant tissues ... South Dakota School of Mines & Technology researcher Congzhou Wang, Ph.D., these ideas are ... to monitor and prevent disease,” says Wang. , Wang, an assistant professor in ...
Breaking Biology News(10 mins):
(Date:7/26/2019)... ... July 25, 2019 , ... LeadingBiotech , an exclusive ... announces its Boston BD conference to be held on September 10, ... Boston , the event provides an opportunity for attendees to leverage insight from ...
(Date:7/17/2019)... , ... July 16, 2019 ... ... long-term strategic agreement for the development and manufacturing of Zolgensma® (onasemnogene abeparvovec-xioi), ... this collaboration, AveXis, a Novartis company, will have dedicated manufacturing space at ...
(Date:7/2/2019)... ... July 02, 2019 , ... Leading Regenerative Veterinary Medicine company, ... Where Beasts Meet Biotech. The film focuses on regenerative veterinary medicine as a ... Pharm was recently included in the Brentwood and Pacific Palisades International Film ...
(Date:6/11/2019)... ... June 10, 2019 , ... Thought Technology Ltd is ... of Biofeedback Tech Ltd as its authorised distributor for the UK ... many therapeutic treatments and clinical assessment protocols to treat stress related disorders as ...
Breaking Biology Technology:
Cached News: